BSL Raffles Medical
- 1.020
- -0.010-0.97%
Raffles Medical News
Executive Chairman & CEO of Raffles Medical Group Choon Yong Loo Buys More Stock
Raffles Medical Group (SGX:BSL) Could Be A Buy For Its Upcoming Dividend
These 4 Measures Indicate That Raffles Medical Group (SGX:BSL) Is Using Debt Reasonably Well
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Express News | Singapore plans to boost the local stock market and is studying relevant proposals
Raffles Medical Group Announces Board Changes
Raffles Medical Group's (SGX:BSL) Returns Have Hit A Wall
Raffles Medical Group Full Year 2023 Earnings: EPS Misses Expectations
Raffles Medical Group (SGX:BSL) Will Pay A Smaller Dividend Than Last Year
Union Steel Co-founder Ang Yew Chye Ups Stake
INSTITUTIONS continued to be net buyers of Singapore stocks over the four trading sessions through to Mar 27, with S$211 million of net institutional inflow, as 22 primary-listed companies conducted b
Raffles Medical Group Ltd (SGX:BSL) Shares Could Be 34% Below Their Intrinsic Value Estimate
Raffles Medical Chair Continues Purchases; Sam Goi Ups PSC Stake
Institutions were net buyers of Singapore stocks over the five trading sessions through to Mar 21, with S$257 million of net institutional inflow, as 23 primary-listed companies conducted buybacks wit
Loo Continues Raffles Medical Share Spree as Weekly Tally Climbs to 500,000 Units
Raffles Medical CEO Loo Acquires 100,000 Shares at $1.03 Each
Raffles Medical Executive Chair Continues Acquisitions, CDL Leads Buyback Consideration
GRAPHIC: HANNAH KWAHInstitutions were net sellers of Singapore stocks over the five trading sessions through to Mar 14, with S$156 million of net institutional outflow, as 24 primary-listed companies
An Intrinsic Calculation For Raffles Medical Group Ltd (SGX:BSL) Suggests It's 34% Undervalued
Key Insights Raffles Medical Group's estimated fair value is S$1.58 based on 2 Stage Free Cash Flow to Equity Raffles Medical Group is estimated to be 34% undervalued based on current share price of
Business Activity Expands in Singapore's Private Sector in February as Demand Improves
Business activity in Singapore's private sector expanded in February, thanks to improving demand, driving a record rise in employment during the month, S&P Global reported Tuesday.
Executive Chairman & CEO of Raffles Medical Group Picks Up 1.7% More Stock
CGS-CIMB Research Adjusts Raffles Medical Group's Price Target to SG$1.16 From SG$1.20, Keeps at Buy
04:07 AM EST, 02/29/2024 (MT Newswires) -- CGS-CIMB Research Adjusts Raffles Medical Group's Price Target to SG$1.16 From SG$1.20, Keeps at Buy Price (SGD): S$1.02, Change: S$0.00, Percent Change: 0.0
Raffles Medical Group's Near-Term Earnings Prospects Seem Lackluster -- Market Talk
0722 GMT - Raffles Medical Group's near-term earnings prospects seem lackluster after posting worse-than-expected 2023 results, Phillip Securities Research analyst Paul Chew says in a commentary. The
Raffles Medical Group Target Price Lowered to S$0.96 From S$1.02 by Phillip Securities Research >BSL.SG
Raffles Medical Group Target Price Lowered to S$0.96 From S$1.02 by Phillip Securities Research >BSL.SG
Analysis
Price Target
No Data
